Coherus Oncology, Inc.

Coherus Biosciences Inc. is a biotechnology company focused on developing, manufacturing, and commercializing biosimilar products. Biosimilars are highly similar to existing, approved biological medicines with no clinically meaningful differences in terms of safety or efficacy. Coherus Biosciences aims to provide more accessible biological therapeutics in key therapeutic areas such as oncology, ophthalmology, and immunology. By doing so, the company addresses the need for more cost-effective treatment options and aims to contribute to the sustainability of healthcare systems globally. Coherus Biosciences operates within a highly regulated market, collaborating with healthcare providers, payers, and patients to enhance treatment options and availability. Founded in 2010 and headquartered in Redwood City, California, the company leverages its specialized research and development capabilities to expand its portfolio, providing competitive alternatives to high-cost biologics and playing a significant role in the biotechnology and healthcare sectors by fostering innovation and reducing healthcare costs.